The EU’s drug regulator has so far said there is no evidence that tailored vaccines are needed against the Omicron variant of the coronavirus. Meanwhile, Ursula von der Leyen at a press conference on Thursday night, at the end of a regular summit with EU leaders, said: “Member states have agreed to launch a first tranche of more than 180 million additional doses of adapted vaccines, in our third contract with BioNTech-Pfizer.”
According to the World Health Organization (WHO), it has a large number of mutations, some of which are worrisome.
Initial evidence indicates that the risk of re-infection with this variant is higher than with other worrisome variants, and the number of cases it causes appears to be increasing in almost all South African provinces.
For now, the PCR tests used to diagnose SARS-CoV-2 continue to detect this variant. In addition, in South Africa and around the world, researchers are conducting studies to better understand many aspects of it and will continue to report their results as they become available.
Source From: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
